Price History
Feb 9, 2026 — May 23, 2026Investment Snapshot
- Trading 2% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 17.1% — good return on equity
- Revenue growing at 10% annually
Humana Inc. Common Stock (HUM) is a Financial Services company operating in Hospital & Medical Service Plans, listed on the NYSE , with a market capitalisation of $37.0 billion . Key value metrics: P/E ratio 11.7, P/B ratio 1.99, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Humana Inc. Common Stock — Fundamental Analysis Summary
Humana Inc. Common Stock (HUM) is currently trading 2% above its Graham Number of $303.21, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a low trailing P/E ratio of 11.7x.
On financial health, HUM shows a moderate Piotroski F-Score of 5/9, and solid return on equity of 17.1% (sector average: 4.9%), and manageable leverage with a debt-to-equity ratio of 0.75.
StockPik's composite Value Score for HUM is 83/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HUM shows revenue growing at 10% year-over-year, with earnings declining at 2%.
HUM pays a modest dividend yield of 1.1%.